Tool
Supplement comparison tool
Pick up to 4 knowledge base entries and compare their dosage, price, evidence strength and ratings side by side — you can save or share a link to your selection.
Add to comparison (2/4)
| Category | Leki | Leki |
| Evidence strength | Strong evidence | Strong evidence |
| Evidence Score | 4/5 | 5/5 |
| User rating | 4.5 (76) | 4.5 (168) |
| Typical dose | Determined individually by a doctor, usually 500–2000 mg daily in divided doses, with meals | Topical form: 1 ml of 5% solution or the equivalent foam dose, applied twice daily to dry scalp (women sometimes use 5% foam once daily or a 2% solution). Oral form (LDOM, off-label): typically 0.625-5 mg/day, most often 1.25-2.5 mg, individually dosed by a physician |
| Form | Oral tablets, including extended-release (XR) forms that reduce gastrointestinal discomfort | Topical solution or foam; tablets split for the oral form (compounding pharmacy preparation) |
| Average price | — | 35-90 zł za opakowanie formy miejscowej starczające na miesiąc stosowania (cena zależy od koncentracji, formy i producenta — generyki są tańsze niż marki oryginalne) |
| Monthly cost | — | ok. 35-90 zł/miesiąc dla formy miejscowej; forma doustna (receptura) zwykle wychodzi wyraźnie taniej, ale wymaga recepty i wizyty lekarskiej |
| Time to effects | Lowering of glycemia is usually visible within days to weeks of starting therapy and reaching the target dose. | The temporary shedding phase can appear as early as weeks 2-8 of treatment. The first visible signs of regrowth usually appear after 3-4 months of consistent use, with a fully assessable clinical effect after 6-12 months of uninterrupted treatment. The effect requires indefinite continuation; it fades within a few months of stopping. |
| Who it's for | People with type 2 diabetes or prediabetes, qualified by a doctor | Men with early- to moderate-stage androgenetic alopecia, especially in the crown area (less effective where follicles are already completely lost in advanced frontal balding) |